Cellply

🤝🏼Thank you to everyone who stopped by our booth at CAR-TCR Summit Series in Boston! Missed us at the Summit? No worries! Join our technical webinar about uncovering hidden immune cell killing to understand anti-tumor activity. #CellTherapy #Immunotherapy

⏳ Don't miss the opportunity to join our Webinar with Francesco Imperatore, Field Application Scientist at Cellply Hear how to uncover hidden killing of immune cells to understand anti-cancer activity. This webinar is part of the 𝗘𝘂𝗿𝗼𝗽𝗲𝗮𝗻 𝗕𝗶𝗼𝘁𝗲𝗰𝗵 𝗪𝗲𝗲𝗸 program, in which Cellply is participating, an event all over Europe to celebrate biotechnology and its applications. 📅 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟮𝟲 - 𝗘𝗨𝗥𝗢𝗣𝗘𝗔𝗡 𝗦𝗘𝗦𝗦𝗜𝗢𝗡 🕑 02.00 p.m CEST Sign up here ➡️ https://lnkd.in/d5DPgv5x 📅 𝗦𝗲𝗽𝘁𝗲𝗺𝗯𝗲𝗿 𝟯𝟬 - 𝗨𝗦 𝗦𝗘𝗦𝗦𝗜𝗢𝗡 🕑 09.00 am PDT | 12.00 pm EDT Sign up here ➡️https://lnkd.in/d-CYajJW #Biotechweek #Webinar #CellTherapy #Immunotherapy

📢 Exciting news! Cellply is thrilled to take part in the 2nd Summer School & Annual Meeting of the Horizon Europe-funded OncoProTools Doctoral Network in Madrid! 𝗧𝗵𝗶𝘀 𝗶𝗻𝗶𝘁𝗶𝗮𝘁𝗶𝘃𝗲 𝗯𝗿𝗶𝗻𝗴𝘀 𝘁𝗼𝗴𝗲𝘁𝗵𝗲𝗿 𝗹𝗲𝗮𝗱𝗶𝗻𝗴 𝗲𝘅𝗽𝗲𝗿𝘁𝘀 𝗶𝗻 𝗼𝗻𝗰𝗼𝗹𝗼𝗴𝘆, 𝗰𝗮𝗻𝗰𝗲𝗿 𝗱𝗶𝗮𝗴𝗻𝗼𝘀𝘁𝗶𝗰𝘀, 𝗶𝗺𝗺𝘂𝗻𝗼𝗹𝗼𝗴𝘆, 𝗮𝗻𝗱 𝗺𝗲𝗱𝗶𝗰𝗮𝗹 𝗰𝗵𝗲𝗺𝗶𝘀𝘁𝗿𝘆 𝘁𝗼 𝗱𝗲𝘃𝗲𝗹𝗼𝗽 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝘃𝗲 𝗽𝗿𝗼𝘁𝗲𝗮𝘀𝗲 𝘁𝘂𝗺𝗼𝗿-𝘁𝗮𝗿𝗴𝗲𝘁𝗶𝗻𝗴 𝘀𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗲𝘀. Our MSCA PhD researcher Héctor Caballero González, alongside Laura Rocchi, our Head of Biology, are proud to contribute to this important collaboration, leveraging our novel single-cell immunophenotyping technology. We look forward to the discussions and breakthroughs that will emerge from this dynamic network! #H2021 #CancerResearch #CellTherapy

🚀 We are ready to welcome you to our booth at the 9th CAR-TCR Summit in Boston! ➡️ 𝗕𝗢𝗢𝗧𝗛 #𝟳𝟳 We’re proud to showcase VivaCyte, our next-generation platform that’s transforming cancer immunotherapy and cell-based biotherapeutics research. 𝗝𝗼𝗶𝗻 𝘂𝘀 𝗮𝘁 𝘁𝗵𝗲 𝗳𝗼𝗿𝗲𝗳𝗿𝗼𝗻𝘁 𝗼𝗳 𝗶𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻! Let's connect and explore how Cellply’s solutions can accelerate the future of cell therapy. Stay connected with us 🌐 https://www.cellply.com/ #CARTCRSummit #CellTherapy #Immunotherapy

🔬Join us for a cutting-edge Webinar on discovering immune cell subsets with dominant anti-tumor activity. 🎤 𝗦𝗽𝗲𝗮𝗸𝗲𝗿: Francesco Imperatore, Field Application Scientist at Cellply 📍 𝗛𝗼𝘀𝘁𝗲𝗱 𝗯𝘆: Cellply This webinar will dive into an innovative approach that could revolutionize cell therapy by identifying hidden immune cells with unique killing properties - without pre-sorting. 📅 𝗘𝗨𝗥𝗢𝗣𝗘𝗔𝗡 𝗦𝗘𝗦𝗦𝗜𝗢𝗡: September 26th 14.00 pm CEST. Register here ➡️ https://lnkd.in/d5DPgv5x 📅𝗨𝗦 𝗦𝗘𝗦𝗦𝗜𝗢𝗡: September 30th 09.00 am PDT | 12.00 pm EDT Register here ➡️ https://lnkd.in/d-CYajJW #Webinar #CellTherapy

📢 We are among the companies that will take part in the Tech Tour 𝐆𝐫𝐨𝐰𝐭𝐡 𝐇𝐞𝐚𝐥𝐭𝐡 𝟐𝟎𝟐𝟒, which will be held in Lausanne on September 10-11. It's an important opportunity to connect with experts and investors and Emiliano Spagnolo and Massimo Bocchi will present our platform, VivaCyte, which can help speed up the research process in the development of cell therapies. #TTGH24 #Biotech #CellTherapy

A week full of events has started! 🌍 📍Meet with Francesco Imperatore at the 𝟯𝙧𝙙 𝘾𝙚𝙡𝙡 𝙏𝙝𝙚𝙧𝙖𝙥𝙮 𝘼𝙣𝙖𝙡𝙮𝙩𝙞𝙘𝙖𝙡 𝘿𝙚𝙫𝙚𝙡𝙤𝙥𝙢𝙚𝙣𝙩 𝙎𝙪𝙢𝙢𝙞𝙩 𝙀𝙪𝙧𝙤𝙥𝙚 in London and discover how measure multiple functional and phenotypic properties on the same immune cells. 📍Meet with Marco Fadda at 𝙄𝙎𝘾𝙏 𝙀𝙪𝙧𝙤𝙥𝙚 in Gothemburg if you are interested in developing and validating a high-throughput analytical testing strategy for full characterization of your immunotherapy product. Hanson Wade Group Keep following us for all the updates! ➡️ https://www.cellply.com/ #CellTherapy #CancerResearch #Immunotherapy

📢We are very proud to announce that strategic partnership with Eurofins BioPharma Product Testing Italy, which will enable cellular therapy developers to access our unique platform which supports the comprehensive characterisation of cells and cell functions at single-cell resolution.  Read more about this partnership ➡️ https://lnkd.in/dsCvffwT #Partnership #CellTherapy #CellFunction

📢 Our team will be present at 3 major events in September: ➊ 𝟯𝙧𝙙 𝘾𝙚𝙡𝙡 𝙏𝙝𝙚𝙧𝙖𝙥𝙮 𝘼𝙣𝙖𝙡𝙮𝙩𝙞𝙘𝙖𝙡 𝘿𝙚𝙫𝙚𝙡𝙤𝙥𝙢𝙚𝙣𝙩 𝙎𝙪𝙢𝙢𝙞𝙩 𝙀𝙪𝙧𝙤𝙥𝙚 – London. If you are il London and want to discover our Analytical method contact Francesco Imperatore. ➋ 𝙄𝙎𝘾𝙏 𝙀𝙪𝙧𝙤𝙥𝙚 – Gothemburg. Contact Marco Fadda if you are interested in developing and validating a high-throughput analytical testing strategy for full characterization of your immunotherapy product. ➌ 𝟵𝙩𝙝 𝘾𝘼𝙍-𝙏𝘾𝙍 𝙎𝙪𝙢𝙢𝙞𝙩 – Boston. Come to visit us at 𝑩𝑶𝑶𝑻𝑯 #77 and discover our full automated platform to streamline cell therapy discovery and development. Here Mark Atlas and Francesco Imperatore will show you our technology. Stay tuned for updates! 🌐 https://cellply.com/ Hanson Wade Group #CellTherapy #CancerResearch #Immunotherapy

⏳Don't miss the opportunity to join our Webinar with Richard Harbottle, Head of DNA Vector Lab at DKFZ German Cancer Research Center, and Massimo Bocchi, Co-founder of Cellply. Hear how the DNA Vector Research Group at German Cancer Research Center (DKFZ) employed VivaCyte to advance their #TCR-T cell research and optimization processes, informed by this in-depth characterization data. 📅 11 July 🕑 08:00 PST | 11:00 EST | 17:00 CEST Sign up here ➡️ https://lnkd.in/djJrr-Vq #Webinar #CellTherapy #TCR